| Literature DB >> 34968250 |
Francesca Casciaro1, Giuseppe Persico2, Martina Rusin2,3, Stefano Amatori3, Claire Montgomery4, Jennifer R Rutkowsky4, Jon J Ramsey4, Gino Cortopassi4, Mirco Fanelli3, Marco Giorgio1,2.
Abstract
BACKGROUND: Women represent the majority of Alzheimer's disease patients and show typical symptoms. Genetic, hormonal, and behavioral mechanisms have been proposed to explain sex differences in dementia prevalence. However, whether sex differences exist in the epigenetic landscape of neuronal tissue during the progression of the disease is still unknown.Entities:
Keywords: Alzheimer’s disease; PSAPP mice; histone marks; sex differences
Year: 2021 PMID: 34968250 PMCID: PMC8715457 DOI: 10.3390/epigenomes5040026
Source DB: PubMed Journal: Epigenomes ISSN: 2075-4655
Figure 1Spearman correlation including autosomes and X chromosome. Spearman correlation heatmap including chromosomes 1-19 and X for H3K4me3 (a), H3K27ac (c), and H3K27me3 (e) from cortexes are represented in the graphs on the left side. Corresponding graphs from gastrocnemius, for H3K4me3 (b), H3K27ac (d), and H3K27me3 (f), are reported on the right side. Male IDs are indicated in blue, female IDs are in pink. The color within each cell represents the Spearman coefficient which ranges from 0.68 to 1 (maximal correlation).
Figure 2Signal around TSS of H3K4me3, H3K27ac, and H3K27me3 in cortex and gastrocnemius tissues. H3K4me3 (a–f), H3K27ac (g–l), and H3K27me3 (m–r) average density signal around TSS (±2.5 kb) is plotted for cortex and gastrocnemius as indicated, for chromosomes 1–19 and X on the left, only autosomes in the middle and only X on the right. Males are indicated in blue, females in pink.
Figure 3Feature distribution of called peaks for H3K4me3, H3K27ac, and H3K27me3 in cortex and gastrocnemius tissues. Feature distribution of the identified peaks for H3K4me3 (a), H3K27ac (c), and H3K27me3 (e) in cortexes are reported on the left. Feature distribution of H3K4me3 (b), H3K27ac (d), and H3K27me3 (f) peaks found in the gastrocnemius are reported in the plots on the right. Males are in blue, females in pink. The color code indicating each genomic feature is shown.
Figure 4Principal component analysis of Diffbind consensus peak sets. Principal component analysis of the signals from regions selected after differential binding analysis are graphed. The left column reports information on H3K4me3, the middle one reports on H3K27ac, while H327me3 is analyzed on the right part of the figure.
Differentially bound sites of H3K4me3, H3K27ac, and H3K27me3 in cortex and gastrocnemius tissues. The number of the differentially bound sites (FDR < 0.1) found in each comparison is reported.
| Histone Modification | Chromosomes | N° of db Sites in Cortex | N° db Sites in Gastrocnemius |
|---|---|---|---|
| Autosomes | 2 | 139 | |
| H3K4me3 | X chromosome | 65 | 102 |
| Autosomes | 2 | 781 | |
| H3K27ac | X chromosome | 56 | 69 |
| H3K27me3 | Autosomes | 5 | 206 |
| X chromosome | 2783 | 855 |
Biological signatures associated to H3K27me3-regulated promoters on the X chromosome in cortex. Results of an ingenuity pathway analysis for promoters differentially marked by H3K27me3 in X chromosome from PSAPP cortex are reported. Only terms with an activation z-score above |2| are considered. All the results are presented as increased/decreased in females with respect to males.
| Cortex Diseases or Functions | Predicted Activation State | Activation Z-Score | Molecules | N° of Molecules | |
|---|---|---|---|---|---|
| Spatial learning | 2.70 × 10−5 | Increased | 2.646 | AP1S2,ARHGEF9,CYBB,DLG3,Gprasp2,GRIPAP1,HTR2C, KDM5C, MECP2, OPHN1,PHF8,SLC6A8,UBE2A, ZDHHC9 | 14 |
| Growth of neurites | 4.98 × 10−3 | Increased | 2.138 | AR,ARX,CCDC120,CDKL5,DCX,EFNB1,ELK1,FRMD7, GJB1, MAO, MID1,OGT,PLXNA3,RAB33A,SLC25A5, SNX12,SYN1,TLR7,TRPC5 | 19 |
| Organization of cytoskeleton | 1.17 × 10−7 | Increased | 2.074 | AGTR2,AMOT,AR,ARHGAP4,ARHGAP6,ARHGEF9, ATP7A, BRWD3,CAPN6,CDK16,CDKL5,CETN2,CUL4B, CXCR3,CYBB, DCX,DGKK,DLG3,DOCK11,EFNB1,ELK1, F8A1 (includes others),FGD1,FLNA,FRMD7,GATA1,GDI1,GJB1,GPM6B, Gprasp2,HDAC6,HDAC8,HPRT1, IL1RAPL1,KDM5C,MAOA, MECP2,MID1,MID1IP1, mir-384,MPP1,MTM1,NR0B1,OFD1, OGT,OPHN1,PAK3, PCYT1B,PLS3,PLXNA3,PLXNB3,POF1B, PQBP1,RAB33A, RPGR,RPS6KA3,SH3KBP1,SHROOM2, SHROOM4, SLITRK2,SYN1,TLR7,Tmsb4x (includes others), TRPC5, USP9X | 65 |
| Organization of cytoplasm | 8.76 × 10−7 | Increased | 2.074 | AGTR2,AMOT,AR,ARHGAP4,ARHGAP6,ARHGEF9, ATP7A, BRWD3,CAPN6,CDK16,CDKL5,CETN2,CUL4B,CXCR3,CYBB, DCX,DGKK,DLG3,DOCK11,EFNB1,ELK1,F8A1(includes others),FGD1,FLNA,FRMD7,GATA1,GDI1,GJB1,GPM6B, Gprasp2,HCFC1,HDAC6,HDAC8,HPRT1,HSD17B10, IL1RAPL1,KDM5C,MAOA,MECP2,MID1,MID1IP1,mir-384, MPP1,MTM1,NR0B1,OFD1,OGT,OPHN1,PAK3,PCYT1B,PLS3,PLXNA3,PLXNB3,POF1B,PQBP1,RAB33A,RPGR,RPS6KA3, SH3KBP1,SHROOM2, SHROOM4, SLITRK, SYN1,TLR7, Tmsb4x (includes others),TRPC5,USP9X | 67 |
| Tremor | 1.14 × 10−3 | Decreased | −2.011 | ARAF,CA5B,GABRQ,GJB1,GPM6B,GRIA3,IKBKG,MECP2, | 10 |
| Differentiation of Th2 cells | 1.09 × 10−2 | Decreased | −2.236 | FOXP3,GATA1,IL13RA2,let-7,TLR7 | 5 |
| Movement Disorders | 2.29 × 10−3 | Decreased | −2.242 | ABCB7,AIFM1,AMER1,AP1S2,AR,ARAF,ARHGEF9,ARMCX2, AR, ATP6AP2,BCAP31,CA5B,CDKL5,CETN2,CXCR3,F8A1 (includes others),GABRQ,GJB1,GPM6B,GRIA3,GRPR,HPRT1, HTR2C,IDS,IGSF1,IKBKG,KCND1,MAOA,MECP2,OGT,PDK3, PGK1,PGRMC1,PLP1,PRKX,PTCHD1,RGN,RS1,SRPX,SRPX2, SYN1,SYTL4,TIMP1,Tmsb4x (includes others),XIAP | 45 |
| Motor dysfunction or movement disorder | 1.72 × 10−3 | Decreased | −2.666 | ABCB7,AIFM1,AMER1,AP1S2,AR,ARAF,ARHGEF9,ARMCX2, AR,ATP6AP2,BCAP31,CA5B,CDKL5,CETN2,CXCR3,F8A1 (includes others),GABRQ,GJB1,GPM6B,GRIA3,GRPR,HPRT1, HTR2C,IDS,IGSF1,IKBKG,KCND1,MAOA,MECP2,MTM1, OGT, PDK3,PGK1,PGRMC1,PLP1,PRKX,PTCHD1,RGN,RS1, | 46 |
Biological signatures associated to H3K27me3-regulated promoters on gastrocnemius X chromosome. Results of an ingenuity pathway analysis for promoters differentially marked by H3K27me3 in X chromosome from PSAPP gastrocnemius are reported. Only terms with an activation z-score above |2| are taken in consideration. All the results are presented as regulated (increased/decreased) in females with respect to males.
| Gastrocnemius Diseases or Functions (H3K27me3 X) | Predicted Activation State | Activation Z-Score | Molecules | N° of Molecules | |
|---|---|---|---|---|---|
| Organization of actin cytoskeleton | 27.23 × 10−3 | Increased | 2.000 | ARHGAP4,EFNB1,FGD1,GPM6B,MSN,OPHN1,PAK3,PLS3, Tmsb4x (includes others) | 9 |
| Abdominal cancer | 1.41 × 10−5 | Decreased | −2.000 | ABCB7,ACE2,AIFM1,AMER1,ARHGAP36,ARHGAP4,ARHGEF9, ARMCX1,ARMCX2,ARMCX3,ARMCX4,ARMCX5,ARX, ASB9, ATP2B3,AVPR2,AWAT2,BCOR,BCORL1,BEX1,BGN, BMX,BRS3, BTK,CA5B,CACNA1F,CCDC160,CD40LG, CDX4,CHRDL1, CLDN2,CNGA2,CNKSR2,COL4A5,DACH2,DCAF12L2,DGAT2L6,DOCK11, DUSP9, EFNB1,EGFL6,ELF4,ERCC6L,FAM155B, FGD1,FOXO4,FOXR2,FRMD7,FRMPD3,GABRA3,GABRQ,GATA1, GDPD2,GJB1,GPC3,GPC4,GPM6,GPR101,GPR143, GPR50,GRIA3, GRPR,GSPT2,GUCY2F,HCFC1,HDAC8, HPRT1,HSD17B1,HTR2C, IDH3G,IGSF1,IL13RA1,IL1RAPL1,IL1RAPL2, IQSEC2,IRAK1, KCND1,KCNE5,KLF8,KLHL15,L1CAM, LANCL3,LHFPL1, LONRF3,MAGEA10, MAGEA11,MAGED1,MAGEE1,MAGEE2, MAP7D2,MBNL3,mir-452,MSN,NAA10,NAP1L2,NEXMIF,NONO, NRK,NYX,OGT,OPHN1,OPN1LW,OTUD6A,PAK3,PCDH11X, PCDH19,PDK3,PDZD4,PHF6,PHKA1,PLAC1,PLS3,PLXNA3, PLXNB3,PNMA3,PNMA5,PRKX,PRPS1,PRPS2,PTCHD1, RAB33A, RAI2,RAP2C,RBM41,RNF128,RPS4Y1,RRAGB,SLC16A2,SLC25A43,SLC38A5,SLC6A8,SLC7A3,SLITRK4,SOWAHD,SOX3,SRPX, STARD8,SYN1,SYTL4,TAB3,TAF1,TBX22,TCEANC,THOC2, TMEM164,TMEM255A,TMEM47,TREX2, TRPC5,TSC22D3,TSPYL2, UPF3B,USP51,UTP14A,VGLL1,YIPF6,ZC4H2, ZCCHC12, ZDHHC9,ZFX,ZIC3,ZMYM3 | 162 |